Clinical and Pathological Studies in the Oldest Old
Clinical and Pathological Studies in the Oldest Old
批准号:
7796652
负责人:
CLAUDIA H. KAWAS
金额:
$138.21万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2013-02-28
关键词:
Activities of Daily LivingAgeAged, 80 and overAlzheimer&aposs DiseaseAnemiaBiologicalBlood VesselsCaliforniaCentenarianClinicalClinical DataCognitionCognitiveCohort StudiesCollaborationsDNADataDementiaDevelopmentExerciseFutureGeneticGoalsHippocampus (Brain)Impaired cognitionIncidenceIndividualInterventionIntervention StudiesInvestigationLaboratory StudyLifeMeasuresNeuronsNonagenarianOther GeneticsOxygenOxygen Therapy CarePathologyPennsylvaniaPerformancePopulationProspective StudiesPublic HealthResearch PersonnelResourcesRiskRisk FactorsSamplingScientistSocietiesSpeedSurveysTestingUniversitiesWalkingage groupage relatedagedbasebrain tissuedisabilityfrailtyfunctional declinefunctional disabilityfunctional statusmedical schoolsmemberpopulation basedpreventprospectivepublic health relevanceresearch studysynucleintau-1
中文摘要
描述(由申请人提供):项目摘要启动于2003年,90+研究的目标是在90岁及以上人群中进行前瞻性临床,病理和遗传研究。凭借90+研究中丰富的认知测试,实验室研究,身体表现测量,遗传和其他数据,以及自1981年以来作为休闲世界队列研究的一部分收集的关于这些人的调查信息,我们将估计发病率并评估痴呆症(目标1),功能残疾和虚弱(目标2)的风险和保护因素,以及老年人的认知和功能下降(目标3)。我们的研究强调了潜在的可改变因素(氧饱和度,贫血和身体表现)作为该年龄组痴呆和残疾的危险因素,并可能为未来最年长老年人的干预研究提供基础。基于我们的初步研究,我们假设动脉血氧饱和度差是认知能力下降和痴呆的危险因素,而贫血和身体表现指标(如步行速度和握力)是痴呆和非痴呆个体发生残疾、虚弱和功能下降的危险因素。在这个年龄段的所有痴呆症受试者中,有一半没有明显的经典AD或其他病理来解释认知丧失。在这项应用中,新的合作加强了我们的临床病理学研究,调查最古老的老年人认知的生物学相关性(目的4)。来自我们充分表征的受试者的脑组织将由加州大学欧文分校、宾夕法尼亚大学和约翰霍普金斯医学院的研究者进行研究,因为我们测试了我们的假设,即可溶性而不是不溶性的A2、tau和1突触核蛋白寡聚体种类可能是90岁以上奥尔兹人认知丧失的原因(Aim 4b),与神经元完整性和回路相关的衰老可能通过其他年龄相关机制导致认知丧失(目的4c)。最后,我们将开发我们的临床数据和生物样本(脑组织和DNA),作为与世界各地科学家积极共享的资源。项目叙述理解影响我们社会中最高级成员的认知和功能状态的因素是本提案的主要目标。在我们对老年痴呆症、残疾和虚弱的前瞻性研究中,我们将调查动脉血氧饱和度、贫血、体能指标和其他可能适合干预的因素与痴呆症、残疾和虚弱的关系。最终,我们的目标是找到延长九十岁和百岁老人无残疾寿命的方法。如果低氧饱和度,贫血或身体表现差与异常长寿的痴呆或残疾风险增加有关,则将为实验研究提供基础,以确定氧疗,贫血治疗或运动是否可以预防或延迟老年人认知和日常生活活动的丧失。对我们人口中增长最快的部分来说,潜在的公共卫生影响是巨大的。公共卫生相关性:了解影响我们社会最高级成员的认知和功能状态的因素是本提案的主要目标。在我们对高龄老人痴呆、残疾和虚弱的前瞻性研究中,我们将调查动脉血氧饱和度、贫血、体能指标和其他可能适合干预的因素与痴呆、残疾和虚弱的关系。最终,我们的目标是找到延长九十岁和百岁老人无残疾寿命的方法。如果低氧饱和度,贫血或身体表现不佳与痴呆或残疾的风险增加有关,在特别长的寿命中,它将为实验研究提供基础,以确定氧疗,贫血治疗或运动是否可以预防或延迟认知和日常生活活动的丧失。对我们人口中增长最快的部分来说,潜在的公共卫生影响是巨大的。
英文摘要
DESCRIPTION (provided by applicant): Project Summary Initiated in 2003, the goal of The 90+Study is to perform prospective clinical, pathological, and genetic investigations in a population based sample of people aged 90 years and older. With a wealth of cognitive tests, laboratory studies, physical performance measures, genetic and other data in The 90+ Study, plus survey information collected on these individuals since 1981 as part of the Leisure World Cohort Study, we will estimate incidence rates and evaluate risk and protective factors for dementia (Aim 1), functional disability and frailty (Aim 2), as well as cognitive and functional decline in the oldest old (Aim 3). Our studies emphasize potentially modifiable factors (oxygen saturation, anemia, and physical performance) as risk factors for dementia and disability in this age group, and could potentially provide the basis for future intervention studies in the oldest old. Based on our preliminary studies, we hypothesize that poor arterial oxygen saturation is a risk factor for cognitive decline and dementia, while anemia and physical performance measures (such as walk speed and handgrip) are risk factors for the development of disability, frailty, and functional decline in demented and non demented individuals. Half of all demented subjects in this age range do not have significant classical AD or other pathologies to explain cognitive loss. In this application, new collaborations enhance our clinical pathological studies investigating the biological correlates of cognition in the oldest old (Aim 4). Brain tissues from our well characterized subjects will be studied by investigators at the University of California, Irvine, University of Pennsylvania, and Johns Hopkins School of Medicine as we test our hypotheses that soluble, rather than insoluble, oligomeric species of A2, tau and 1 synuclein may be responsible for cognitive loss in 90+ year olds (Aim 4b) and that non AD pathologies, relevant to neuronal integrity and circuits, may contribute to cognitive loss through other age related mechanisms (Aim 4c). Finally, we will develop our clinical data and biological samples (brain tissues and DNA) as a resource to be actively shared with scientists worldwide. Project Narrative Understanding factors that influence the cognitive and functional status of the most senior members of our society is a major goal of this proposal. In our prospective studies of dementia, disability, and frailty in the oldest old, we will investigate the relationship to dementia, disability, and frailty of arterial O2 saturation, anemia, physical performance measures, and other factors that might be amenable to intervention. Ultimately our goal is to find ways to extend life without disability in nonagenarians and centenarians. If low O2 saturation, anemia or poor physical performance is associated with increased risk of dementia or disability in exceptionally long life, it would provide the basis for experimental studies to determine if oxygen therapy, treatment of anemia, or exercise could prevent or delay the loss of cognition and activities of daily living in the oldest old. The potential public health implications are enormous for the fastest growing segment of our population. PUBLIC HEALTH RELEVANCE: Understanding factors that influence the cognitive and functional status of the most senior members of our society is a major goal of this proposal. In our prospective studies of dementia, disability, and frailty in the oldest-old, we will investigate the relationship to dementia, disability, and frailty of arterial O2 saturation, anemia, physical performance measures, and other factors that might be amenable to intervention. Ultimately our goal is to find ways to extend life without disability in nonagenarians and centenarians. If low O2 saturation, anemia or poor physical performance is associated with increased risk of dementia or disability in exceptionally long life, it would provide the basis for experimental studies to determine if oxygen therapy, treatment of anemia, or exercise could prevent or delay the loss of cognition and activities of daily living in the oldest-old. The potential public health implications are enormous for the fastest growing segment of our population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B-Clinical Core
-
批准号:9922101
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2020
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:8166929
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2009
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:7951079
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2008
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
CORE--CLINICAL
-
批准号:6932809
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2005
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6578726
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8230622
-
项目类别:
-
资助金额:$136.92万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7463369
-
项目类别:
-
资助金额:$134.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6907727
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6578728
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6934497
-
项目类别:
-
资助金额:$119.18万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7496763
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6659008
-
项目类别:
-
资助金额:$104.62万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6782570
-
项目类别:
-
资助金额:$119.2万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6507991
-
项目类别:
-
资助金额:$109.34万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7575781
-
项目类别:
-
资助金额:$134.86万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8039091
-
项目类别:
-
资助金额:$135.73万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7112272
-
项目类别:
-
资助金额:$118.38万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6448161
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6448159
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6299255
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2000
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: